NewGenIVF raises K25.ai stake to 13% in $7.5 million deal

The Nasdaq-listed company said the 3% purchase values K25.ai at $250 million and will be partly funded with about 2.5 million Class A ordinary shares tied to listing compliance.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.